← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Texas Sw Med Ctr/Dallas
Dallas, TX
$781,793,787
Total funding
1,150
Grants
Funding mix
By agency
NIH$794,619,516 · 1152
By mechanism
R01$468,442,105 · 452
M01$66,628,943 · 165
U01$53,149,695 · 26
P01$39,345,021 · 79
R37$30,379,412 · 21
T32$27,670,271 · 20
Investigators at University Of Texas Sw Med Ctr/Dallas
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
ALLIANCE FOR CELLULAR SIGNALING - PHASE II$9,164,988
U54 · FY2003 · GM
ALLIANCE FOR CELLULAR SIGNALING - PHASE II$9,164,980
U54 · FY2004 · GM
ALLIANCE FOR CELLULAR SIGNALING - PHASE II$9,052,430
U54 · FY2002 · GM
ALLIANCE FOR CELLULAR SIGNALING - PHASE II$8,990,326
U54 · FY2001 · GM
ALLIANCE FOR CELLULAR SIGNALING - PHASE II$8,779,351
U54 · FY2000 · GM
Alliance for Cellular Signaling$6,164,375
U54 · FY2005 · GM
Molecular Basis of Cholesterol Metabolism$5,136,272
P01 · FY2005 · HL
Molecular Basis of Cholesterol Metabolism$4,986,672
P01 · FY2004 · HL
Molecular Basis of Cholesterol Metabolism$4,841,430
P01 · FY2003 · HL
Molecular Basis of Cholesterol Metabolism$4,700,415
P01 · FY2002 · HL
MOLECULAR BASIS OF CHOLESTEROL METABOLISM$4,277,091
P01 · FY2001 · HL
MOLECULAR BASIS OF CHOLESTEROL METABOLISM$4,152,487
P01 · FY2000 · HL
Intracellular Pathways Relevant to Human cancer$3,671,807
P01 · FY2005 · CA
Intracellular Pathways Relevant to Human cancer$3,571,363
P01 · FY2004 · CA
GENOMICS AND PROTEOMICS OF CELL INJURY AND INFLAMMATION$3,497,854
U01 · FY2000 · HL
GENOMICS AND PROTEOMICS OF CELL INJURY AND INFLAMMATION$3,490,990
U01 · FY2002 · HL
GENOMICS AND PROTEOMICS OF CELL INJURY AND INFLAMMATION$3,489,736
U01 · FY2003 · HL
GENOMICS AND PROTEOMICS OF CELL INJURY AND INFLAMMATION$3,488,308
U01 · FY2001 · HL
GENERAL CLINICAL RESEARCH CENTER$3,457,567
M01 · FY2005 · RR
Intracellular Pathways Relevant to Human cancer$3,420,050
P01 · FY2003 · CA